Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Morn1 | Rat | (+)-catechin | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of MORN1 mRNA | CTD | PMID:24763279 | Morn1 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MORN1 mRNA] | CTD | PMID:31150632 | Morn1 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Morn1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MORN1 mRNA | CTD | PMID:36331819 | Morn1 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Morn1 (Mus musculus) | 6480464 | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of MORN1 mRNA | CTD | PMID:31388691 | Morn1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MORN1 mRNA | CTD | PMID:33387578 | Morn1 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Morn1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Morn1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of MORN1 mRNA | CTD | PMID:39298647 | Morn1 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of MORN1 mRNA | CTD | PMID:24780913 | Morn1 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of MORN1 mRNA | CTD | PMID:30047161 | Morn1 | Rat | aflatoxin B1 | decreases expression | ISO | Morn1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of MORN1 mRNA | CTD | PMID:19770486 | Morn1 | Rat | aflatoxin B1 | decreases methylation | ISO | MORN1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of MORN1 intron | CTD | PMID:30157460 | Morn1 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of MORN1 mRNA | CTD | PMID:30047161 | Morn1 | Rat | arsane | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Morn1 | Rat | arsenic atom | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Morn1 | Rat | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of MORN1 mRNA | CTD | PMID:36841081 | Morn1 | Rat | benzo[a]pyrene | decreases expression | ISO | Morn1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MORN1 mRNA | CTD | PMID:19770486 | Morn1 | Rat | benzo[a]pyrene | affects methylation | ISO | MORN1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MORN1 promoter | CTD | PMID:27901495 | Morn1 | Rat | benzo[e]pyrene | increases methylation | ISO | MORN1 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of MORN1 intron | CTD | PMID:30157460 | Morn1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MORN1 mRNA | CTD | PMID:25181051 | Morn1 | Rat | bisphenol A | decreases methylation | ISO | MORN1 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of MORN1 gene | CTD | PMID:31601247 | Morn1 | Rat | bisphenol F | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Morn1 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Morn1 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of MORN1 intron | CTD | PMID:28392331 | Morn1 | Rat | carbon nanotube | decreases expression | ISO | Morn1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of MORN1 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Morn1 | Rat | chlorpyrifos | increases expression | ISO | Morn1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of MORN1 mRNA | CTD | PMID:37019170 | Morn1 | Rat | cisplatin | decreases expression | ISO | MORN1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of MORN1 mRNA | CTD | PMID:27392435 | Morn1 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of MORN1 mRNA | CTD | PMID:26577399 | Morn1 | Rat | dexamethasone | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Morn1 | Rat | Dibutyl phosphate | affects expression | ISO | MORN1 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of MORN1 mRNA | CTD | PMID:37042841 | Morn1 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of MORN1 mRNA | CTD | PMID:29391264 | Morn1 | Rat | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of MORN1 gene | CTD | PMID:22079235 | Morn1 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of MORN1 mRNA | CTD | PMID:25539665|PMID:26194646 | Morn1 | Rat | furan | decreases expression | ISO | Morn1 (Mus musculus) | 6480464 | furan results in decreased expression of MORN1 mRNA | CTD | PMID:24183702 | Morn1 | Rat | genistein | decreases expression | ISO | Morn1 (Mus musculus) | 6480464 | Genistein results in decreased expression of MORN1 mRNA | CTD | PMID:32186404 | Morn1 | Rat | indometacin | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Morn1 | Rat | manganese atom | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Morn1 | Rat | manganese(0) | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Morn1 | Rat | manganese(II) chloride | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Morn1 | Rat | methapyrilene | increases methylation | ISO | MORN1 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of MORN1 intron | CTD | PMID:30157460 | Morn1 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of MORN1 mRNA | CTD | PMID:30047161 | Morn1 | Rat | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of MORN1 mRNA | CTD | PMID:26720608 | Morn1 | Rat | paracetamol | affects expression | ISO | Morn1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MORN1 mRNA | CTD | PMID:17562736 | Morn1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Morn1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MORN1 mRNA | CTD | PMID:36331819 | Morn1 | Rat | propanal | decreases expression | ISO | MORN1 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of MORN1 mRNA | CTD | PMID:26079696 | Morn1 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of MORN1 mRNA | CTD | PMID:19013527 | Morn1 | Rat | sodium arsenite | multiple interactions | ISO | MORN1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Morn1 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of MORN1 mRNA | CTD | PMID:30047161 | Morn1 | Rat | sunitinib | increases expression | ISO | MORN1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of MORN1 mRNA | CTD | PMID:31533062 | Morn1 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of MORN1 mRNA | CTD | PMID:31150632 | Morn1 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MORN1 mRNA] | CTD | PMID:31150632 | Morn1 | Rat | titanium dioxide | affects expression | ISO | Morn1 (Mus musculus) | 6480464 | titanium dioxide affects the expression of MORN1 mRNA | CTD | PMID:23557971 | Morn1 | Rat | triptonide | increases expression | ISO | Morn1 (Mus musculus) | 6480464 | triptonide results in increased expression of MORN1 mRNA | CTD | PMID:33045310 | Morn1 | Rat | urethane | decreases expression | ISO | MORN1 (Homo sapiens) | 6480464 | Urethane results in decreased expression of MORN1 mRNA | CTD | PMID:28818685 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





















